Genexine Inc (095700) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.011x

Based on the latest financial reports, Genexine Inc (095700) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.97 Billion ≈ $-2.02 Million USD) by net assets (₩260.01 Billion ≈ $176.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Genexine Inc market cap and net worth for the company's overall valuation and market capitalisation.

Genexine Inc - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Genexine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genexine Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genexine Inc ranked by their cash flow conversion efficiency. Explore Genexine Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Embellence Group AB ST:EMBELL	0.080x
Kyungdong City Gas Co Ltd KO:267290	0.112x
Concorde International Group Ltd Class A Ordinary Shares NASDAQ:CIGL	-0.157x
Paseco Co. Ltd KQ:037070	-0.036x
Apetit Oyj HE:APETIT	0.118x
Builddirect.com Tehcnologies Inc V:BILD	0.116x
Clipan Finance Indonesia Tbk JK:CFIN	0.093x
Townsquare Media Inc NYSE:TSQ	-0.040x

Annual Cash Flow Conversion Efficiency for Genexine Inc (2009–2024)

The table below shows the annual cash flow conversion efficiency of Genexine Inc from 2009 to 2024. View Genexine Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩261.68 Billion ≈ $177.34 Million	₩-1.65 Billion ≈ $-1.12 Million	-0.006x	+95.09%
2023-12-31	₩296.90 Billion ≈ $201.21 Million	₩-38.05 Billion ≈ $-25.79 Million	-0.128x	+11.07%
2022-12-31	₩276.15 Billion ≈ $187.15 Million	₩-39.80 Billion ≈ $-26.97 Million	-0.144x	-485.45%
2021-12-31	₩517.74 Billion ≈ $350.87 Million	₩-12.75 Billion ≈ $-8.64 Million	-0.025x	+41.89%
2020-12-31	₩535.60 Billion ≈ $362.97 Million	₩-22.69 Billion ≈ $-15.38 Million	-0.042x	+69.74%
2019-12-31	₩296.91 Billion ≈ $201.21 Million	₩-41.57 Billion ≈ $-28.17 Million	-0.140x	-123.77%
2018-12-31	₩320.51 Billion ≈ $217.20 Million	₩-20.05 Billion ≈ $-13.59 Million	-0.063x	+72.70%
2017-12-31	₩113.91 Billion ≈ $77.19 Million	₩-26.10 Billion ≈ $-17.69 Million	-0.229x	-176.72%
2016-12-31	₩170.24 Billion ≈ $115.37 Million	₩-14.10 Billion ≈ $-9.55 Million	-0.083x	-534.09%
2015-12-31	₩125.77 Billion ≈ $85.23 Million	₩-1.64 Billion ≈ $-1.11 Million	-0.013x	-135.88%
2012-12-31	₩45.83 Billion ≈ $31.06 Million	₩1.67 Billion ≈ $1.13 Million	0.036x	+125.17%
2011-12-31	₩24.04 Billion ≈ $16.29 Million	₩-3.48 Billion ≈ $-2.36 Million	-0.145x	+17.18%
2010-12-31	₩26.43 Billion ≈ $17.91 Million	₩-4.62 Billion ≈ $-3.13 Million	-0.175x	-19184.88%
2009-12-31	₩38.50 Billion ≈ $26.09 Million	₩35.23 Million ≈ $23.87K	0.001x	--

About Genexine Inc

KQ:095700 Korea Biotechnology

Market Cap

$87.38 Million

₩128.93 Billion KRW

Market Cap Rank

#19781 Global

#1021 in Korea

Share Price

₩2835.00

Change (1 day)

+1.43%

52-Week Range

₩2195.00 - ₩7100.00

All Time High

₩131402.78